亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Efficacy and Safety of Paclitaxel-Coated Balloon Angioplasty for Dysfunctional Arteriovenous Fistulas: A Multicenter Randomized Controlled Trial

医学 血管成形术 狭窄 靶病变 再狭窄 外科 病变 血液透析 动静脉瘘 临床终点 气球 切割气球 瘘管 随机对照试验 支架 放射科 内科学 经皮冠状动脉介入治疗 心肌梗塞
作者
Yanqi Yin,Yaxue Shi,Tianlei Cui,Hua Li,Jianghua Chen,Lihong Zhang,Zhengya Yu,Hong Li,Yan Yan,Kun Wu,Qizhuang Jin
出处
期刊:American Journal of Kidney Diseases [Elsevier BV]
卷期号:78 (1): 19-27.e1 被引量:60
标识
DOI:10.1053/j.ajkd.2020.11.022
摘要

Previous studies have illustrated the potential superiority of drug-coated balloons (DCBs) in maintaining patency after initial angioplasty for arteriovenous fistula (AVF) dysfunction due to stenosis. Our trial evaluated the efficacy and safety of DCBs for preventing fistula restenosis in Chinese hemodialysis patients.Multicenter, prospective, randomized, open-label, blinded end point, controlled trial.A total of 161 hemodialysis patients with fistula dysfunction from 10 centers in China.Participants were randomized 1:1 to treatment with initial dilation followed by DCB angioplasty or conventional high-pressure balloon (HPB) angioplasty.The primary end point was target lesion primary patency defined as the target lesion intervention-free survival in conjunction with an ultrasonography-measured peak systolic velocity ratio (PSVR) ≤2.0 at 6 months. The secondary end points included 1) device, technical, clinical, and procedural success; 2) major adverse events; 3) degree of target lesion stenosis at 6 months; and 4) clinically driven target lesion and target shunt revascularization within 12 months.The percentage with target lesion primary patency as defined by a PSVR ≤2.0 was higher in the DCB group than in the control group (65% vs 37%, respectively; rate difference, 28% [95% CI, 13%-43%]; P <0.001) at 6 months. The target lesion and target shunt intervention-free survival of the DCB group were not superior to those of the control group at 6 months (P = 0.3 and P = 0.2, respectively) but were superior at 12 months (target lesion intervention-free survival: 73% for DCB vs 58% for control [P = 0.04]; target shunt intervention-free survival: 73% for DCB vs 57% for control [P = 0.04]). The average degree of target lesion stenoses at 6 months was not significantly different between the 2 groups (44% ± 16% for DCB vs 49% ± 18% for control; P = 0.09). There were no significant differences in major adverse events or in device, technical, clinical, or procedural success rates between the groups.Small sample size; short follow-up period; procedural differences between the 2 groups such as unequal inflation times and balloon lengths.Compared to conventional HPB angioplasty, DCB treatment achieved superior primary patency defined using PSVR measured at 6 months and superior intervention-free survival of both the target lesion and the target shunt at 12 months without evidence of greater adverse events.Funded by ZhuHai Cardionovum Medical Device Co., Ltd.Registered at ClinicalTrials.gov with study number NCT02962141.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
3秒前
卿亦佳人发布了新的文献求助10
8秒前
共享精神的应助被凡凡采纳,获得10
14秒前
秋风的应助被Samuel采纳,获得10
19秒前
陨石拿铁完成签到,获得积分10
29秒前
小蘑菇的应助被吴玉婷采纳,获得10
34秒前
称心忆灵完成签到,获得积分10
39秒前
彩色的勒完成签到,获得积分10
49秒前
53秒前
soilman发布了新的文献求助10
58秒前
JamesPei的应助被April采纳,获得10
1分钟前
沉静问芙完成签到,获得积分10
1分钟前
1分钟前
1分钟前
crystal完成签到 ,获得积分10
1分钟前
Fun_112发布了新的文献求助10
1分钟前
DD发布了新的文献求助10
1分钟前
1分钟前
奔跑的应助被科研通管家采纳,获得10
1分钟前
科研通AI65的应助被科研通管家采纳,获得20
1分钟前
1分钟前
1分钟前
April发布了新的文献求助10
1分钟前
激昂的慕山完成签到,获得积分10
1分钟前
1分钟前
思源的应助被Fun_112采纳,获得10
1分钟前
怂怂鼠完成签到,获得积分10
1分钟前
DD完成签到,获得积分20
1分钟前
和风完成签到 ,获得积分10
1分钟前
时之王者发布了新的文献求助10
1分钟前
1分钟前
吴玉婷完成签到,获得积分10
1分钟前
专注的书雁完成签到,获得积分10
1分钟前
JamesPei的应助被mai采纳,获得10
1分钟前
1分钟前
吴玉婷发布了新的文献求助10
1分钟前
猕猴桃发布了新的文献求助10
2分钟前
追寻夜香完成签到 ,获得积分10
2分钟前
2分钟前
大胆半双完成签到,获得积分10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185091
求助须知:如何正确求助?哪些是违规求助? 9574009
关于积分的说明 21833941
捐赠科研通 7782532
什么是DOI,文献DOI怎么找? 3434500
关于科研通互助平台的介绍 2558701
邀请新用户注册赠送积分活动 2481201